Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non‐small‐cell lung cancer

BACKGROUND AND AIM: Immune checkpoint inhibitors have significantly improved the clinical outcomes of many cancer types, but they induce a range of immune‐related adverse events (irAEs). Although adrenal insufficiency (AI) is a rare irAE, it can lead to serious consequences. This study aimed to dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurokawa, Kana, Mitsuishi, Yoichiro, Shimada, Naoko, Ito, Naoaki, Ogiwara, Misa, Miura, Keita, Asao, Tetsuhiko, Ko, Ryo, Shukuya, Takehito, Shibayama, Rina, Goto, Hiromasa, Takahashi, Kazuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925336/
https://www.ncbi.nlm.nih.gov/pubmed/36523162
http://dx.doi.org/10.1111/1759-7714.14761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925336/
https://www.ncbi.nlm.nih.gov/pubmed/36523162
http://dx.doi.org/10.1111/1759-7714.14761

Ejemplares similares